80 likes | 224 Views
Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, structure, synthesis, and immunogenicity. Biologic products are generally characterized by high molecular weight and complex structures. These products are usually derived from living entities and are less easily characterized compared to small molecules. These products are often susceptible to extreme temperatures and light. TechNavio's analysts forecast the Global Biologic Therapeutics market to grow at a CAGR of 8.22 percent over the period 2013-2018. Complete report is available at : http://www.researchbeam.com/global-biologic-therapeutics-2014-2018-market
E N D
Global Biologic Therapeutics Market 2014-2018 (Type, Mode of action, Crop Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com Published on : Oct 2014
Report Overview Research Beam adds a report titled "Global Biologic Therapeutics Market 2014-2018". The report provides an in-depth study on the Biologic Therapeutics Market industry trends,opportunities and factors influencing the market. About Biologic Therapeutics Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, structure, synthesis, and immunogenicity. Biologic products are generally characterized by high molecular weight and complex structures. These products are usually derived from living entities and are less easily characterized compared to small molecules. These products are often susceptible to extreme temperatures and light. TechNavio's analysts forecast the Global Biologic Therapeutics market to grow at a CAGR of 8.22 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Global Biologic Therapeutics market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of the following drugs: • Protein therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics) • Vaccines (pediatric vaccines and adult vaccines) • Cell therapy
Report Overview The Other Protein Therapeutics segment covers proteins such as cytokines, fusion proteins, peptide antibiotics, peptide hormones, and blood factors. TechNavio's report, Global Biologic Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biologic Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Regions • Americas • APAC • EMEA Key Vendors • Amgen • F. Hoffmann-La Roche • Novo Nordisk • Sanofi Other Prominent Vendors • Abbvie • AstraZeneca • Bavarian Nordic • Baxter International
Report Overview Market Driver • Aging Population • For a full, detailed list, view our report Market Challenge • Requirement of Cold Storage • For a full, detailed list, view our report Market Trend • Emergence of Targeted and Combination Therapies • For a full, detailed list, view our report Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? Complete report is available at : http://www.researchbeam.com/global-biologic-therapeutics-2014-2018-market
Table of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape 06.1 Market Overview 06.2 Market Size and Forecast 06.3 Five Forces Analysis 07. Market Segmentation by Molecule Type
Table of Contents 08. Geographical Segmentation 09. Buying Criteria 10. Global Protein Therapeutics Market 10.1 Introduction 10.2 Drivers, Challenges and Trends 10.3 Market Size and Forecast 10.4 Market Segmentation by Molecule Type 10.4.1 Global Monoclonal Antibodies Market 10.4.2 Global Enzymes Market 10.4.3 Global Other Protein Therapeutics Market 11. Global Vaccines Market 11.1 Introduction 11.2 Drivers, Challenges and Trends 11.3 Market Size and Forecast 12. Global Cell Therapy Market 12.1 Introduction 12.2 Drivers, Challenges and Trends
Similar Market Studies • Published Reports • Purchase Enquire of Report : • http://www.researchbeam.com/global-biologic-therapeutics-2014-2018-market/purchase-enquiry • Similar market studies : • Global Ultrasonic Flowmeter Market 2014-2018 • Global Tissue Diagnostics Market 2014-2018 • Global Polymerase Chain Reaction (PCR) Market 2014-2018
FOR MORE DETAILS Visit us at : www.researchbeam.com/global-biologic-therapeutics-2014-2018-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com